Market Overview

Illumina Announces Phasing Analysis Service


Illumina, Inc. (NASDAQ: ILMN) today announced the availability of its
Phasing Analysis Service, provided by the company's FastTrack Services
lab through the Illumina Genome Network (IGN). The new sample-to-answer
service delivers human whole-genome phase information, empowering gene
mapping studies with a more comprehensive view of genomic variation.
With phase data, researchers can better understand the effect of
genotype on phenotype and variant interaction within a gene.

Conventionally, whole-genome sequencing generates a single consensus
sequence without assigning variants to specific homologous
chromosomes. Phase information, however, can identify segments of
connected variants, facilitating ancestry determination in population
studies. Further, in instances where two potentially deleterious
variants occur in a gene, knowing how these

See full press release

Posted-In: Earnings News Guidance Contracts Management Global


Related Articles (ILMN)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

CafePress Names Garett Jackson CIO

Benzinga Market Primer: Thursday, July 18: Key Tech Earnings Today!